A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination

被引:9
|
作者
Experton, Bettina [1 ]
Tetteh, Hassan A. [2 ]
Lurie, Nicole [3 ,4 ]
Walker, Peter [5 ]
Elena, Adrien [1 ]
Hein, Christopher S. [1 ]
Schwendiman, Blake [1 ]
Vincent, Justin L. [6 ]
Burrow, Christopher R. [1 ]
机构
[1] Humetrix Inc, Del Mar, CA 90214 USA
[2] Dept Def Joint Artificial Intelligence Ctr JAIC, Warfighter Hlth Mission Team, Arlington, VA 22202 USA
[3] Coalit Epidem Preparedness Innovat CEPI, Washington, DC 20006 USA
[4] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[5] US Navy, Washington, DC 20376 USA
[6] Amazon Web Serv Inc, Seattle, WA 98109 USA
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 11期
关键词
COVID-19 vaccine prioritization; COVID-19 booster vaccine; severe COVID-19 disease; risk for severe COVID-19 infection; COVID-19 vaccine booster prioritization; Medicare population; severe COVID-19 risk model;
D O I
10.3390/biology10111185
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple SummaryWhether it is for COVID-19 primary vaccination or the administration of booster vaccines, prioritization criteria need to be established to optimize COVID-19 vaccination programs accounting for both clinical and social vulnerability risks for severe COVID-19 disease. We developed a dual socio-clinical risk model for severe COVID-19 disease in the Medicare population, which is comprised mostly of individuals aged 65 and over. Our model generated risk levels correlated with regionalized COVID-19 case hospitalization rates and mapped them at the county and zip code levels. The model and map can be used by health jurisdictions to reach out to unvaccinated individuals. Our model approach can also be applied to identify Medicare beneficiaries who were in early vaccination groups to be vaccinated to identify those who might maximally benefit from an additional dose of COVID-19 vaccine if and when vaccine immunity wanes.Recommendations for prioritizing COVID-19 vaccination have focused on the elderly at higher risk for severe disease. Existing models for identifying higher-risk individuals lack the needed integration of socio-demographic and clinical risk factors. Using multivariate logistic regression and random forest modeling, we developed a predictive model of severe COVID-19 using clinical data from Medicare claims for 16 million Medicare beneficiaries and socio-economic data from the CDC Social Vulnerability Index. Predicted individual probabilities of COVID-19 hospitalization were then calculated for population risk stratification and vaccine prioritization and mapping. The leading COVID-19 hospitalization risk factors were non-white ethnicity, end-stage renal disease, advanced age, prior hospitalization, leukemia, morbid obesity, chronic kidney disease, lung cancer, chronic liver disease, pulmonary fibrosis or pulmonary hypertension, and chemotherapy. However, previously reported risk factors such as chronic obstructive pulmonary disease and diabetes conferred modest hospitalization risk. Among all social vulnerability factors, residence in a low-income zip code was the only risk factor independently predicting hospitalization. This multifactor risk model and its population risk dashboard can be used to optimize COVID-19 vaccine allocation in the higher-risk Medicare population.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] COVID-19 booster exemption for severe dyshidrotic eczema
    Bentivegna, Kathryn
    Rothe, Marti J.
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (05) : 1087 - 1088
  • [32] COVID-19 booster recommendations
    不详
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2021, 99 (09) : 613 - 613
  • [33] Autoimmunity, COVID-19, Post-COVID 19 Syndrome and COVID-19 Vaccination
    Ashkenazi, S.
    Shoenfeld, Yehuda
    Dotan, Arad
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2023, 25 (02): : 161 - 162
  • [34] The COVID-19 vaccination
    Casas, Irma
    Mena, Guillermo
    MEDICINA CLINICA, 2021, 156 (10): : 500 - 502
  • [35] Severe rash after COVID-19 vaccination
    Haque, Kabiul
    Flowers, Ashley
    Haas, Christopher
    Mayeaux, Edward John
    Usatine, Richard P.
    JOURNAL OF FAMILY PRACTICE, 2023, 72 (04): : 185 - 187
  • [36] COVID-19 vaccination and a severe pain in the neck
    Kyriacou, Angelos
    Ioakim, Stamatina
    Syed, Akheel A.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 94 : 95 - 96
  • [37] Association between COVID-19 Booster Vaccination and COVID-19 Outcomes among U.S. Adults
    Nguyen, Kimberly H.
    McChesney, Cheyenne
    Patel, Ruchi
    Bednarczyk, Robert A.
    Vasudevan, Lavanya
    Corlin, Laura
    VACCINES, 2024, 12 (05)
  • [38] VACCINATION FOR COVID-19 ATTENUATES IN-HOSPITAL CARDIAC COMPLICATIONS IN THE SETTING OF SEVERE COVID-19
    Basala, Thomas R.
    Dulas, Marissa E.
    Albers, Alexis
    Bergstedt, Seth
    Olson, Sara D.
    Traverse, Jay H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1781 - 1781
  • [39] Do Side Effects to the Primary COVID-19 Vaccine Reduce Intentions for a COVID-19 Vaccine Booster?
    Geers, Andrew L.
    Clemens, Kelly S.
    Colagiuri, Ben
    Jason, Emily
    Colloca, Luana
    Webster, Rebecca
    Vase, Lene
    Seig, Mette
    Faasse, Kate
    ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (08) : 761 - 768
  • [40] Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination
    Iba, Toshiaki
    Levy, Jerrold H.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2022, 32 (05) : 249 - 256